(Q33371187)

26 July 2017

1 reference

title

'Rescue' therapies for the management of Helicobacter pylori infection (English)

1 reference

Helicobacter pylori infectious disease

26 July 2017

0 references

1 reference

Francesco Di Mario

1

1 reference

PubMed ID

16699270

26 July 2017

Lucas G Cavallaro

series ordinal

2

1 reference

PubMed ID

16699270

26 July 2017

Carmelo Scarpignato

series ordinal

3

1 reference

26 July 2017

1 January 2006

1 reference

26 July 2017

1 reference

26 July 2017

24

1 reference

26 July 2017

1-2

1 reference

26 July 2017

113-130

1 reference

Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries

26 July 2017

1 reference

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

21 January 2018

1 reference

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

21 January 2018

1 reference

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

21 January 2018

1 reference

Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy

21 January 2018

1 reference

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

21 January 2018

1 reference

High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study

21 January 2018

1 reference

Helicobacter pylori infection and chronic gastric acid hyposecretion

21 January 2018

1 reference

Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years.

21 January 2018

1 reference

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration

21 January 2018

1 reference

Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status

21 January 2018

1 reference

Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002

21 January 2018

1 reference

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

21 January 2018

1 reference

Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime

21 January 2018

1 reference

Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin.

21 January 2018

1 reference

Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan

21 January 2018

1 reference

The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001).

21 January 2018

1 reference

Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases

21 January 2018

1 reference

The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance

21 January 2018

1 reference

Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico

21 January 2018

1 reference

Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil

21 January 2018

1 reference

A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates

21 January 2018

1 reference

Review article: treatment of Helicobacter pylori infection and factors influencing eradication

21 January 2018

1 reference

Daily regimen and compliance with treatment

21 January 2018

1 reference

A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy.

21 January 2018

1 reference

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

21 January 2018

1 reference

cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia

21 January 2018

1 reference

Review article: the treatment of refractory Helicobacter pylori infection

21 January 2018

1 reference

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype

21 January 2018

1 reference

Pharmacogenetics of the proton pump inhibitors: a systematic review.

21 January 2018

1 reference

Towards the ideal regimen for Helicobacter pylori eradication: the search continues

21 January 2018

1 reference

The effects of nocturnal acid breakthrough on Helicobacter pylori eradication

21 January 2018

1 reference

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

21 January 2018

1 reference

Helicobacter pylori: the challenge in therapy

21 January 2018

1 reference

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

21 January 2018

1 reference

Basis for the management of drug-resistant Helicobacter pylori infection

21 January 2018

1 reference

Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts

21 January 2018

1 reference

Regular review: treatment of Helicobacter pylori infection

21 January 2018

1 reference

Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection

21 January 2018

1 reference

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection

21 January 2018

1 reference

Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection

21 January 2018

1 reference

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

21 January 2018

1 reference

High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection

21 January 2018

1 reference

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

21 January 2018

1 reference

Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

21 January 2018

1 reference

Second‐line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

21 January 2018

1 reference

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

21 January 2018

1 reference

Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.

21 January 2018

1 reference

A triple therapy regimen after failed Helicobacter pylori treatments

21 January 2018

1 reference

A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy

21 January 2018

1 reference

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

21 January 2018

1 reference

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

21 January 2018

1 reference

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

21 January 2018

1 reference

Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.

21 January 2018

1 reference

Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin

21 January 2018

1 reference

In vitro activity of rifaximin against Helicobacter pylori.

21 January 2018

1 reference

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

21 January 2018

1 reference

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

21 January 2018

1 reference

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial

21 January 2018

1 reference

A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

21 January 2018

1 reference

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial

21 January 2018

1 reference

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients

21 January 2018

1 reference

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

21 January 2018

1 reference

Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.

21 January 2018

1 reference

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

21 January 2018

1 reference

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

21 January 2018

1 reference

Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection

21 January 2018

1 reference

Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments

21 January 2018

1 reference

Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgG1, IgG2, IgM) acting alone or in combination.

21 January 2018

1 reference

Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection

21 January 2018

1 reference

Use of lactoferrin for Helicobacter pylori eradication. Preliminary results

21 January 2018

1 reference

Use of bovine lactoferrin for Helicobacter pylori eradication

21 January 2018

1 reference

Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.

21 January 2018

1 reference

Lactoferrin: milking ulcers?

21 January 2018

1 reference

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis

21 January 2018

1 reference

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

N-acetylcysteine, a novel treatment for Helicobacter pylori infection

21 January 2018

1 reference

Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori

21 January 2018

1 reference

Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells

21 January 2018

1 reference

Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract

21 January 2018

1 reference

Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial

21 January 2018

1 reference

Oral broccoli sprouts for the treatment of Helicobacter pylori infection: a preliminary report

21 January 2018

1 reference

Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods

21 January 2018

1 reference

Antimicrobial activity of essential oils against Helicobacter pylori.

21 January 2018

1 reference

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection

21 January 2018

1 reference

A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication

21 January 2018

1 reference

Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

21 January 2018

1 reference

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

21 January 2018

1 reference

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090315

1 reference

26 July 2017

1 reference

PubMed ID

16699270